Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	KAPPOS Ludwig GOLD Ralf MILLER David H. MACMANUS David G. HAVRDOVÁ Eva LIMMROTH Volker POLMAN Chris H. SCHMIERER Klaus YOUSRY Tarek A. YANG Minhua ERAKSOY Mefkure MELUZÍNOVÁ Eva REKTOR Ivan DAWSON Katherine D. SANDROCK Alfred W. O'NEILL Gilmore N.
Year of publication	2008
Type	Article in Periodical
Magazine / Source	Lancet
MU Faculty or unit	Faculty of Medicine
Citation
Field	Neurology, neurosurgery, neurosciences
Keywords	Multiple sclerosis; multicentre; randomised; placebo
Description	Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Related projects:	The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions.